Drug Efficacy Study: Final Report to the Commissioner of Food and Drugs - Food and Drug Administration (1969)

Chapter: APPENDIX B. 8 PANEL ON DRUGS USED IN HEMATOLOGIC DISORDERSand PANEL ON ANTINEOPLASTIC DRUGS

Previous Chapter: APPENDIX B. 7 PANELS ON DRUGS USED IN GASTROENTEROLOGY
Suggested Citation: "APPENDIX B. 8 PANEL ON DRUGS USED IN HEMATOLOGIC DISORDERSand PANEL ON ANTINEOPLASTIC DRUGS." National Research Council. 1969. Drug Efficacy Study: Final Report to the Commissioner of Food and Drugs - Food and Drug Administration. Washington, DC: The National Academies Press. doi: 10.17226/24615.
Page 197
Suggested Citation: "APPENDIX B. 8 PANEL ON DRUGS USED IN HEMATOLOGIC DISORDERSand PANEL ON ANTINEOPLASTIC DRUGS." National Research Council. 1969. Drug Efficacy Study: Final Report to the Commissioner of Food and Drugs - Food and Drug Administration. Washington, DC: The National Academies Press. doi: 10.17226/24615.
Page 198
Suggested Citation: "APPENDIX B. 8 PANEL ON DRUGS USED IN HEMATOLOGIC DISORDERSand PANEL ON ANTINEOPLASTIC DRUGS." National Research Council. 1969. Drug Efficacy Study: Final Report to the Commissioner of Food and Drugs - Food and Drug Administration. Washington, DC: The National Academies Press. doi: 10.17226/24615.
Page 199
Suggested Citation: "APPENDIX B. 8 PANEL ON DRUGS USED IN HEMATOLOGIC DISORDERSand PANEL ON ANTINEOPLASTIC DRUGS." National Research Council. 1969. Drug Efficacy Study: Final Report to the Commissioner of Food and Drugs - Food and Drug Administration. Washington, DC: The National Academies Press. doi: 10.17226/24615.
Page 200
Suggested Citation: "APPENDIX B. 8 PANEL ON DRUGS USED IN HEMATOLOGIC DISORDERSand PANEL ON ANTINEOPLASTIC DRUGS." National Research Council. 1969. Drug Efficacy Study: Final Report to the Commissioner of Food and Drugs - Food and Drug Administration. Washington, DC: The National Academies Press. doi: 10.17226/24615.
Page 201
Suggested Citation: "APPENDIX B. 8 PANEL ON DRUGS USED IN HEMATOLOGIC DISORDERSand PANEL ON ANTINEOPLASTIC DRUGS." National Research Council. 1969. Drug Efficacy Study: Final Report to the Commissioner of Food and Drugs - Food and Drug Administration. Washington, DC: The National Academies Press. doi: 10.17226/24615.
Page 202
Suggested Citation: "APPENDIX B. 8 PANEL ON DRUGS USED IN HEMATOLOGIC DISORDERSand PANEL ON ANTINEOPLASTIC DRUGS." National Research Council. 1969. Drug Efficacy Study: Final Report to the Commissioner of Food and Drugs - Food and Drug Administration. Washington, DC: The National Academies Press. doi: 10.17226/24615.
Page 203
Suggested Citation: "APPENDIX B. 8 PANEL ON DRUGS USED IN HEMATOLOGIC DISORDERSand PANEL ON ANTINEOPLASTIC DRUGS." National Research Council. 1969. Drug Efficacy Study: Final Report to the Commissioner of Food and Drugs - Food and Drug Administration. Washington, DC: The National Academies Press. doi: 10.17226/24615.
Page 204
Suggested Citation: "APPENDIX B. 8 PANEL ON DRUGS USED IN HEMATOLOGIC DISORDERSand PANEL ON ANTINEOPLASTIC DRUGS." National Research Council. 1969. Drug Efficacy Study: Final Report to the Commissioner of Food and Drugs - Food and Drug Administration. Washington, DC: The National Academies Press. doi: 10.17226/24615.
Page 205
Suggested Citation: "APPENDIX B. 8 PANEL ON DRUGS USED IN HEMATOLOGIC DISORDERSand PANEL ON ANTINEOPLASTIC DRUGS." National Research Council. 1969. Drug Efficacy Study: Final Report to the Commissioner of Food and Drugs - Food and Drug Administration. Washington, DC: The National Academies Press. doi: 10.17226/24615.
Page 206
Suggested Citation: "APPENDIX B. 8 PANEL ON DRUGS USED IN HEMATOLOGIC DISORDERSand PANEL ON ANTINEOPLASTIC DRUGS." National Research Council. 1969. Drug Efficacy Study: Final Report to the Commissioner of Food and Drugs - Food and Drug Administration. Washington, DC: The National Academies Press. doi: 10.17226/24615.
Page 207
Suggested Citation: "APPENDIX B. 8 PANEL ON DRUGS USED IN HEMATOLOGIC DISORDERSand PANEL ON ANTINEOPLASTIC DRUGS." National Research Council. 1969. Drug Efficacy Study: Final Report to the Commissioner of Food and Drugs - Food and Drug Administration. Washington, DC: The National Academies Press. doi: 10.17226/24615.
Page 208
Suggested Citation: "APPENDIX B. 8 PANEL ON DRUGS USED IN HEMATOLOGIC DISORDERSand PANEL ON ANTINEOPLASTIC DRUGS." National Research Council. 1969. Drug Efficacy Study: Final Report to the Commissioner of Food and Drugs - Food and Drug Administration. Washington, DC: The National Academies Press. doi: 10.17226/24615.
Page 209
Suggested Citation: "APPENDIX B. 8 PANEL ON DRUGS USED IN HEMATOLOGIC DISORDERSand PANEL ON ANTINEOPLASTIC DRUGS." National Research Council. 1969. Drug Efficacy Study: Final Report to the Commissioner of Food and Drugs - Food and Drug Administration. Washington, DC: The National Academies Press. doi: 10.17226/24615.
Page 210
Suggested Citation: "APPENDIX B. 8 PANEL ON DRUGS USED IN HEMATOLOGIC DISORDERSand PANEL ON ANTINEOPLASTIC DRUGS." National Research Council. 1969. Drug Efficacy Study: Final Report to the Commissioner of Food and Drugs - Food and Drug Administration. Washington, DC: The National Academies Press. doi: 10.17226/24615.
Page 211
Suggested Citation: "APPENDIX B. 8 PANEL ON DRUGS USED IN HEMATOLOGIC DISORDERSand PANEL ON ANTINEOPLASTIC DRUGS." National Research Council. 1969. Drug Efficacy Study: Final Report to the Commissioner of Food and Drugs - Food and Drug Administration. Washington, DC: The National Academies Press. doi: 10.17226/24615.
Page 212
Next Chapter: APPENDIX B. 9 PANEL ON DRUGS USED IN ENDOCRINE DISTURBANCES and PANEL ON DRUGS USED IN METABOLIC DISORDERS
Subscribe to Emails from the National Academies
Stay up to date on activities, publications, and events by subscribing to email updates.